Michael F. Cola
CIK: 0001188940
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 19, 2026PHAT
Phathom Pharmaceuticals, Inc.
Award(A)Direct24.1K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
21.5K shares- - Jun 11, 2025SAGE
Sage Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
21.5K shares- - Jun 3, 2025PHAT
Phathom Pharmaceuticals, Inc.
Award(A)Direct10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 |  PHAT Phathom Pharmaceuticals, Inc. | Award(A) | 24,122 | - | $0 | Direct |
| Jul 31, 2025 |  SAGE Sage Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jun 11, 2025 | SAGE Sage Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jun 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award(A) | 10,500 | - | - | Direct |
1-4 of 4 transactions
About COLA MICHAEL F
COLA MICHAEL F (SEC CIK 0001188940) files insider reports with the SEC as Director of Phathom Pharmaceuticals, Inc. (PHAT) and Director of Sage Therapeutics, Inc. (SAGE).
Signal8 holds 4 ownership filings by COLA MICHAEL F, all Form 4s, filed between Jun 5, 2025 and May 21, 2026. Those filings report 4 transactions, from Jun 3, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on COLA MICHAEL F's filings is in FLORHAM PARK, NJ.
Recent filings by COLA MICHAEL F
Other insiders filing for Phathom Pharmaceuticals, Inc. (PHAT)
- Narula Sanjeev, Chief Financial & Bus. Officer
- Breedlove Robert Charles, Principal Accounting Officer
- Parikh Asit, Director
- Topper James N, Director
- Stenhouse Mark, Director
- FIELDS HEIDI, Director